Rain Therapeutics Inc.
NASDAQ:RAIN
1.21 (USD) • At close January 25, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|
| Operating Activities: | ||||
| Net Income
| -75.724 | -51.394 | -21.083 | -10.902 |
| Depreciation & Amortization
| 0.08 | 0.071 | 0.052 | 0.028 |
| Deferred Income Tax
| 0 | 0.08 | 0 | 0 |
| Stock Based Compensation
| 4.855 | 3.092 | 0.865 | 0.236 |
| Change In Working Capital
| 8.93 | 5.188 | 1.609 | -0.827 |
| Accounts Receivables
| 0 | 0 | 0 | 0 |
| Inventory
| 0 | 0 | 0 | 0 |
| Accounts Payables
| 1.034 | 5.288 | 0.555 | -0.249 |
| Other Working Capital
| 7.896 | -0.1 | 1.054 | -0.578 |
| Other Non Cash Items
| -1.34 | 5.5 | 7.326 | 0.283 |
| Operating Cash Flow
| -63.199 | -37.463 | -11.231 | -11.182 |
| Investing Activities: | ||||
| Investments In Property Plant And Equipment
| -0.008 | -2.628 | -5.191 | -0.144 |
| Acquisitions Net
| -0.047 | 2.5 | 0 | 0 |
| Purchases Of Investments
| -76.198 | -163.557 | 0 | 0 |
| Sales Maturities Of Investments
| 123.4 | 47.95 | 0 | 0 |
| Other Investing Activites
| 0.047 | -2.5 | 0 | 0 |
| Investing Cash Flow
| 47.194 | -118.235 | -5.191 | -0.144 |
| Financing Activities: | ||||
| Debt Repayment
| 0 | 0 | 0 | 0 |
| Common Stock Issued
| 0 | 133.366 | 0.001 | 0 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 |
| Other Financing Activities
| 0.053 | -11.751 | 69.49 | 2.5 |
| Financing Cash Flow
| 0.053 | 121.615 | 69.491 | 2.5 |
| Other Information: | ||||
| Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0 |
| Net Change In Cash
| 37.175 | -34.083 | 53.069 | -8.826 |
| Cash At End Of Period
| 61.955 | 24.78 | 58.863 | 5.794 |